Table 1

Markers over expressed in astrocytic cancer cells (GND > C).

Gene

symbol

Accession

number

Fold change


CSRP1

NM_004078

57.34


HSPA1A

NM_005345

28.56


TUBB2B

NM_178012

19.70


GPNMB

NM_001005340

17.55


PSMD5

NM_005047

17.52


PTPRD

NM_002839

12.00


APOE

NM_000041

11.27


MAGEH1

NM_014061

10.26


TYW3

NM_138467

9.56


SESN3

NM_144665

8.03


CTSH

NM_004390

7.88


CRYZ

NM_001889

7.81


PIK3R1

NM_181523

6.50


TAF9B

NM_015975

6.17


ETV1

NM_004956

6.08


GUCY1A3

NM_000856

5.87


GPRC5B

NM_016235

5.84


CPXM1

NM_019609

5.38


HDAC9

NM_178423

5.15


GUCY1B3

NM_000857

4.76


SIPA1L2

NM_020808

4.47


HNMT

NM_006895

4.29


SHMT1

NM_004169

3.46


THRB

NM_001128177

3.13


A subset of gene transcripts derived from Additional file 5, Table S4 exhibiting at least three-fold over expression in trisomic BG01V APCs (G), glioblastoma samples (N) and CCF-STTG1 astrocytoma cells (D) relative to diploid H9 APCs (C), which was obtained by filtering data using a p value < 0.02. Fold change was derived from the GNvC group comparison in Additional file 5, Table S4.

Gopalakrishna-Pillai and Iverson BMC Medical Genomics 2010 3:12   doi:10.1186/1755-8794-3-12

Open Data